This release is a segment of a full release published here.
Driving Innovation in Life Sciences Through Research, Collaboration, and Investment
Launched in 2016, the Peixe Rosa Program is a transformative initiative designed to bolster Latin America’s biopharmaceutical sector. By integrating a Contract Research Organization (CRO), a Scientific and Technological Park, and plans for an Advanced Center for Translational Medicine, the program is revolutionizing the life sciences industry.
Key projects include:
- AMPARO: A recombinant human protein solution addressing infectious diseases, ulcers, and cancer, optimizing healthcare resources and affordability.
- Vacsyn: Innovative therapies and vaccines targeting HIV/AIDS with a focus on enhanced immune responses.
- NanoSensing: Nanotechnology-based diagnostic tools for rapid detection of acute myocardial infarction markers, transforming emergency care.
- Mimesis Hackathon: Engaging students in collaborative science and technology challenges to drive innovation.
Through partnerships with renowned Brazilian institutions, the program attracts substantial foreign investment, aiming to position Brazil as a biopharmaceutical hub. This collaborative vision strengthens access to healthcare while advancing economic growth and global visibility for the region.
Note: Featured image is the Sudene building in Pernambuco, Brazil. The building has been provided to support International Companies coming to Brazil under the Peixe Rosa Program.
